News 2019

« BACK

Pharmacology



Results 1 - 20 of 35.


Pharmacology - Health - 18.03.2019
Caterpillars could hold the secret to new treatment for Osteoarthritis
A substance from a fungus that infects caterpillars could offer new treatment hope for sufferers of osteoarthritis according to new research. Cordycepin is an active compound isolated from the caterpillar fungus Cordyceps militaris and has proved to be effective in treating osteoarthritis by blocking inflammation in a new way, through reducing a process called polyadenylation.

Pharmacology - Health - 13.03.2019
New cholesterol-lowering drug could help patients unable to take statins
New cholesterol-lowering drug could help patients unable to take statins
A new class of oral cholesterol-lowering drug could help patients unable to take statins due to side effects. The findings come from the largest study to date to test the effectiveness and safety of bempedoic acid, an oral medication - yet to be approved in Europe - which inhibits the body's ability to create the building blocks of cholesterol.

Pharmacology - Health - 13.03.2019
Molecular patterns could better predict breast cancer recurrence
The genetic and molecular make-up of individual breast tumours holds clues to how a woman's disease could progress, including the likelihood of it coming back after treatment, and in what time frame, according to a study published in Nature.

Pharmacology - Health - 07.03.2019
Potential new treatment for heart attack
Scientists have found a potential new drug for treating the heart damage caused by a heart attack - by targeting the way the heart reacts to stress. This is the finding of new research, by scientists at Imperial College London and published in the journal Cell Stem Cell. There are no existing therapies that directly address the problem of muscle cell death Professor Michael Schneider Study author The research team, part-funded by the British Heart Foundation (BHF) used stem cells to grow heart tissue and mimic a ‘heart attack in a dish'.

Health - Pharmacology - 06.03.2019
New Hepatitis C cases down by almost 70 per cent in HIV positive men in London
New cases of hepatitis C amongst HIV positive men in London have fallen by nearly 70 per cent in recent years. The new analysis of data from three clinics in London found 256 men were diagnosed between 2013-2018. New infections peaked at 17 for every 1000 people studied in 2015 and fell to six by 2018.

Pharmacology - Health - 05.03.2019
HIV remission achieved in second patient
A second person has experienced sustained remission from HIV-1 after ceasing treatment, reports a paper led by UCL and Imperial College London. The case report comes ten years after the first such case, known as the ‘Berlin Patient.' Both patients were treated with stem cell transplants from donors carrying a genetic mutation that prevents expression of an HIV receptor CCR5.

Life Sciences - Pharmacology - 05.03.2019
Could genetic breakthrough finally help take the sting out of mouth ulcers?
A large breakthrough has been made in the genetic understanding of mouth ulcers which could provide potential for a new drug to prevent or heal the painful lesions. Mouth ulcers affect up to 25 per cent of young adults and a higher proportion of children. Previous research has shown that mouth ulcers are partially heritable, but until now there has been little evidence linking specific genes or genomic regions to mouth ulcers.

Pharmacology - Health - 05.03.2019
HIV remission achieved in second patient
HIV remission achieved in second patient
A second person has experienced sustained remission from HIV-1 after ceasing treatment, according to a study published today in Nature.

Health - Pharmacology - 05.03.2019
’Test and Treat’ reduces new HIV infections by a third in African communities
Results from largest ever HIV prevention trial suggest strategy could make a significant contribution to controlling epidemic New HIV infections in southern Africa could be reduced substantially by offering entire communities voluntary HIV testing, and immediately referring those who test positive for HIV treatment in line with local guidelines, according to new research presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, USA today.

Pharmacology - Health - 04.03.2019
’Game changer’ in treatment of chronic lymphocytic leukaemia
The first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia has been developed at Cardiff University. The technology could guide doctors' decisions on which drugs to give to patients. The Cardiff researchers say that the test could now be a ‘game changer' in the treatment of chronic lymphocytic leukaemia (CLL).

Pharmacology - Health - 28.02.2019
Majority of bipolar patients missing out on the most effective treatments
A quarter of patients with bipolar disorder in Scotland are being prescribed medication that could make symptoms worse and cause serious episodes of mania. The research, led by the University of Glasgow and published today in the British Journal of Psychiatry , reveals that many patients with bipolar disorder in Scotland are on combinations of medication treatments that are out of line with recommended clinical guidelines.

Pharmacology - Health - 27.02.2019
Antibiotic prescribing in primary care
New research on when and how GPs should prescribe antibiotics for common infections is published in The BMJ today [Wednesday 27 February] and is accompanied by an editorial response from the University of Bristol's Centre for Academic Primary Care (CAPC). Primary care is responsible for around 80 per cent of all health service antibiotic prescribing in the UK, with rates likely to be similar worldwide.

Pharmacology - Health - 27.02.2019
Early use of antibiotics in elderly patients associated with reduced sepsis risk
Prescribing antibiotics immediately for elderly patients with urinary tract infections is linked with a reduced risk of sepsis and death. These are the latest findings from researchers at Imperial College London and Public Health England , published in the BMJ.

Health - Pharmacology - 26.02.2019
Steroid treatment for premature babies linked to low birth weight
Steroid injections given to mothers at risk of giving birth prematurely are linked to babies being born with lower body weights. In a study of more than a quarter of a million births, researchers found an association between steroid treatment - used to help an unborn baby's lungs develop - and reduced birth weight.

Life Sciences - Pharmacology - 26.02.2019
Improved outlook for people of African descent with treatment-resistant schizophrenia
A study led by researchers at Cardiff University means that more people of African descent who have treatment-resistant schizophrenia could be safely given the drug best proven to manage their symptoms. The team identified a genetic and benign cause in people of African descent for lower neutrophil levels: a condition that can also be a rare and potentially life-threatening side-effect of the only licensed medication for treatment-resistant schizophrenia.

Health - Pharmacology - 21.02.2019
New care package can improve treatment of people with acute kidney injury
A large clinical trial involving people with acute kidney injury has found that a new package of interventions can significantly improve the diagnosis and treatment of patients, as well as improving their care experience. Acute kidney injury (AKI) is a sudden or rapid decline in kidney function that can lead to hospital admission, longer hospital stays, increased mortality risk and long-term kidney damage.

Pharmacology - Health - 20.02.2019
Long-term benefits from intensive therapy in early stages of MS
New findings by researchers at Cardiff University suggest that intensive therapy during the early stages of multiple sclerosis (MS) leads to better long-term outcomes for patients, despite it often being viewed as a riskier option than other first line treatments. Dr Emma Tallantyre, from Cardiff University's Division of Psychological Medicine and Clinical Neurosciences, said: “Over the last 10-20 years we have seen huge advances in the treatment of relapsing-remitting MS, with over 12 licensed medications having been shown to suppress disease activity.

Health - Pharmacology - 19.02.2019
Seeing the unseeable
Researchers at Cardiff University have used x-ray crystallography and computer simulation to get a closer look at how viruses bind cells and cause infection. The new insight could help in the development of drugs and therapies for infections and further advance the exploitation of viruses for medical treatments.

Health - Pharmacology - 19.02.2019
World's first gene therapy operation for common cause of sight loss carried out
World’s first gene therapy operation for common cause of sight loss carried out
Researchers in Oxford have carried out the world's first gene therapy operation to tackle the root cause of age-related macular degeneration (AMD), the UK's most common cause of sight loss. The procedure was carried out at the John Radcliffe Hospital by Professor Robert MacLaren, Professor of Ophthalmology at the University of Oxford, with the support of the NIHR Oxford Biomedical Research Centre in a clinical trial sponsored by Gyroscope Therapeutics, a UK-based company developing genetically-defined therapies for the treatment of eye diseases.

Health - Pharmacology - 15.02.2019
Artificial intelligence can predict survival of ovarian cancer patients
Artificial intelligence can predict survival of ovarian cancer patients
Researchers have created new machine learning software that can forecast the survival rates and response to treatments of patients with ovarian cancer The artificial intelligence software, created by researchers at Imperial College London and the University of Melbourne , has been able to predict the prognosis of patients with ovarian cancer more accurately than current methods.